Purple Biotech Ltd.

NASDAQ:PPBT

2.4 (USD) • At close July 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016201520142013
Revenue 00.196001110.10000
Cost of Revenue 00.1960000000000
Gross Profit 0-0-0-01110.10000
Gross Profit Ratio 0-0.0010011110000
Reseach & Development Expenses 7.6217.03416.3211.8277.4882.2785.2684.644.182.563.1920.109
General & Administrative Expenses 2.9354.8445.9625.8216.0716.0785.1886.3883.0011.5081.2691.061
Selling & Marketing Expenses 000.321000000000
SG&A 2.9354.8445.9625.8215.7086.0784.4526.3883.0011.5081.2691.061
Other Expenses 0.450.3930.3210.0120.2930.35601.0330000
Operating Expenses 11.005-22.46722.60317.93413.2398.7528.82612.0617.1834.0695.1811.17
Operating Income -11.005-22.271-22.603-17.934-13.239-7.156-7.826-11.966-7.183-4.069-5.181-2.553
Operating Income Ratio 0-113.74100-13.239-7.156-7.826-119.660000
Total Other Income Expenses Net 3.7262.2940.8430.108-15.4621.4792.257-1.042-4.942-0.133-0.071-0.075
Income Before Tax -7.279-19.977-21.76-17.826-28.701-5.893-5.569-12.913-12.125-4.202-5.252-2.628
Income Before Tax Ratio 0-102.02500-28.701-5.893-5.569-129.130000
Income Tax Expense 000.8770.637-15.6690.2160.207-0.710.006-0.0760-1.308
Net Income -7.24-0.02-21.668-18.384-27.999-5.85-5.2-12.177-12.125-4.202-5.252-2.628
Net Income Ratio 0-0.10200-27.999-5.85-5.2-121.770000
EPS -0.028-0.16-0.23-0.21-0.35-0.59-0.7-2.65-4.38-8.75-48.05-61.26
EPS Diluted -0.028-0.16-0.23-0.21-0.35-0.59-0.7-2.65-4.38-8.75-48.05-61.26
EBITDA -7.052-22.225-21.492-17.516-28.41-7.638-5.553-12.883-7.043-4.198-5.231-1.197
EBITDA Ratio 0-113.50600-28.41-7.638-5.553-128.830000